Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial intelligence has secured €7,5 million in an investment round, says the company in a press release. The company is at the forefront of revolutionizing medical treatment and intervention pathways for lung diseases through artificial intelligence technologies, ultimately improving patient care and outcomes.
The company’s capabilities in pre-operative and intra-operative imaging have the potential to significantly enhance the precision, accuracy, and efficiency of (robotic) bronchoscopic and surgical lung interventions, enabling easier-to-perform and less invasive procedures.
Thirona’s LungQ™ platform powers also a growing number of imaging-based exploratory research studies and clinical trials for development of novel pharmaceutical drugs. Having surpassed a total number of 15 million images analyzed, the company evolved to a technologically mature, globally recognized expert in advaced image analysis. With this financing, Thirona plans to accelerate the adoption of its innovations for precision medicine.
Rita Priori, Chief Technology Officer at Thirona: “The future of healthcare is undergoing a transformation, and we are at the forefront of this evolution, leading the way in our field. With the support of the investors, we are well geared to have our technology make a significant impact on patient care and the medical industry.”